Chronological changes of123I-MIBG myocardial scintigraphy and clinical features of Parkinson's disease-Reference-Cited by-同舟云学术

Chronological changes of123I-MIBG myocardial scintigraphy and clinical features of Parkinson's disease

Published:2015-05-02 Issue:9 Volume:86 Page:945-951
ISSN:0022-3050
Container-title:Journal of Neurology, Neurosurgery & Psychiatry
language:en
Short-container-title:J Neurol Neurosurg Psychiatry

Author:

Tsujikawa Koyo,Hasegawa Yasuhiro,Yokoi Satoshi,Yasui Keizo,Nanbu Ichiro,Yanagi Tsutomu,Takahashi Akira

Publisher

BMJ

Subject

Psychiatry and Mental health,Clinical Neurology,Surgery

Reference21 articles.

1. A radiological analysis of heart sympathetic functions with meta-[123I]iodobenzylguanidine in neurological patients with autonomic failure;Hakusui;J Auton Nerv Syst,1994

2. A scintigraphical qualitative analysis of peripheral vascular sympathetic function with meta-[123I]iodobenzylguanidine in neurological patients with autonomic failure;Hirayama;J Auton Nerv Syst,1995

3. Differentiation of idiopathic Parkinson's disease from striatonigral degeneration and progressive supranuclear palsy using iodine-123 meta-iodobenzylguanidine myocardial scintigraphy;Yoshita;J Neurol Sci,1998

4. Loss of 123I-MIBG uptake by the heart in Parkinson's disease: assessment of cardiac sympathetic denervation and diagnostic value;Satoh;J Nucl Med,1999

5. (123)I-metaiodobenzylguanidine myocardial scintigraphy in Parkinson's disease;Orimo;J Neurol Neurosurg Psychiatry,1999

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Associations of cerebrospinal fluid monoamine metabolites with striatal dopamine transporter binding and 123I-meta-iodobenzylguanidine cardiac scintigraphy in Parkinson's disease: Multivariate analyses;Parkinsonism & Related Disorders;2024-11

2. Serum phosphorus levels associated with nigrostriatal dopaminergic deficits in drug-naïve Parkinson's disease;Journal of the Neurological Sciences;2024-09

3. Letter to the editor;Journal of the Neurological Sciences;2024-05

4. Clinical characteristics of patients with Parkinson's disease with reduced 123I-metaiodobenzylguanidine uptake in the major salivary glands and heart;Journal of the Neurological Sciences;2024-03

5. Cardiac sympathetic “morbidity” might reflect the neurobiology of early Parkinson’s disease;Journal of Neurology;2023-10-21